Company Name: Blueprint Medicines Corporation
Blueprint Medicines is a biopharmaceutical company. The company develops kinase inhibitors designed to treat genomically defined cancers and other diseases.
Ticker Symbol: BPMC (NASDAQ)
Company Website: www.blueprintmedicines.com
Social Media:
Headquarters: Cambridge, MA
